• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Airbus sees jet demand conquering suppliers’ output fears

October 6, 2021 by David Barret Leave a Comment

October 6, 2021

By Tim Hepher

BOSTON (Reuters) -Airbus is sticking to its quest for record jet output after airlines reported glimmers of a post-pandemic recovery this week, and believes engine makers who have questioned its most ambitious proposals will be “unable to resist” demand.

Airbus has said it hopes to almost double jet production ina few years as borders reopen. Engine makers fear doing so tooquickly could upset their own recovery, by forcing existing jetsinto retirement rather than their repair shops. Interviewed at the airline industry’s main annual event,Airbus Chief Commercial Officer Christian Scherer held out theprospect that Airbus would play on fierce competition betweenengine makers as it aims to secure future output of its A320neo. “There will be engines. That is the beauty of having enginecompetition in the programme,” he told Reuters on the sidelinesof a meeting of the International Air Transport Association, the first such industry gathering since the pandemic. “There is a lot of rhetoric … (but) at the end of the dayif customers … demand more modern airplanes … no enginemaker in the world is going to be able to resist the call ofnature. So I’m not concerned about it.” Airbus is sold out of its A320neo series until 2026, he said. In May, Airbus issued a mix of firm targets and scenariosthat could lift narrowbody A320-family output to 75 jets a monthby 2025 from about 40 this year, and 60 pre-COVID. The head of France’s Safran, part of the CFM engineventure with General Electric, said earlier this year hewas not sure whether rates above 60 could be sustained. Also speaking in July, Greg Hayes, CEO of Pratt & Whitneyparent Raytheon Technologies, expressed surprise at”pretty aggressive” Airbus output plans. Both engine makers offer competing engines on the A320neo,the most-sold Airbus jet which competes with the Boeing 737 MAX. ‘NO OVERPRODUCTION’ Asked if Airbus had given up on studying the possibility ofincreasing A320neo output beyond the most recent firm target of63 a month to 70 or 75, Scherer said: “absolutely not”. He added: “It is a scenario right now. It is not a committedplan. But it is a sizing exercise that we must do because itcorresponds to demand – verified demand, not theoretical demand– that we are experiencing, including in meetings we are havingright here.”

While IATA discussed tougher climate pledges, airlines,suppliers and leasing companies mingled behind the sceneshaunted by the losses and overdue payments left by the industry’s worst ever crisis, while reporting some interest in new jets. Scherer said conversations were beginning to turn towardsrecovery after a spate of restructurings of plane orders. “The realisation that the world is expecting movementtowards more sustainable, more eco-friendly flying isaccelerating the need for the most modern airplanes, he said. Scherer addressed some suppliers’ concerns that Airbus wouldrace to build jets to meet that demand, but only temporarily,leaving them to absorb costly capacity if the recovery falters. “I think recent history has shown Airbus has been able tomanage its supply and demand very, very rigorously almost to thedot on the right spot,” Scherer said. “You have to trust that we will continue to do that in thefuture and not shoot ourselves in the foot by overproducingairplanes that we can’t sell.”

(Reporting by Tim Hepher, Editing by Louise Heavens and Jane Merriman)

Source Link Airbus sees jet demand conquering suppliers’ output fears

David Barret
David Barret

Related posts:

  1. Bangkok-based insurtech Sunday banks $45M Series B from investors like Tencent
  2. Tennis-Pliskova passes Anisimova test in three-set thriller
  3. US move to dislodge France from Australia submarine deal is incoherent – French ministers
  4. MLB roundup: Cards win 17th straight, seal wild-card bid

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • IFLScience The Big Questions: Will We Ever Have A Universal Flu Vaccine?
  • All Human Languages Mysteriously Obey Zipf’s Law Of Abbreviation. It Applies To Bird Songs Too.
  • California Is Overdue A Massive Earthquake – But We May Have Been Picturing It All Wrong
  • We’re Going On A Bear Hunt: Florida Approves First Black Bear Hunt In 10 Years
  • A Third Of Americans Are Unaware Of HPV; No Wonder Vaccination Rates Are Dangerously Low
  • 80,000-Year-Old Arrowheads Suggest Neanderthals May Have Made Projectile Weapons
  • Uranus Is 12.5 Percent Hotter Than We Thought, And Scientists Want A Closer Look
  • “Land Of The White Jaguar”: 327-Year-Old Letter Leads Researchers To Lost Ancient Maya City
  • The Water In Comet Pons-Brooks Matches The Oceans – Did Comets Help Make Earth Habitable?
  • Peering Down Through A Black Hole’s Cosmic Jet Got Earth Hit By Record-Breaking Neutrinos
  • An Incident In 1888 Sulaymaniyah May Be The Only Confirmed Death By Meteorite
  • In 1883, A Volcano Turned The Sky Red, Sunsets Green, And The Moon Blue For Several Weeks
  • In Antarctica, Linguists Witnessed A New Accent Emerging
  • “Zombie” Rabbits With Freaky “Horns” Alarm Residents In Colorado – What Is Going On?
  • Why Do We Feel Pain? Palliative Expert Dr BJ Miller And Chris Hemsworth Explore The Science Of Pain
  • What Is The Silverpit Crater: The First Meteorite Impact Found Near Great Britain, Or Something Else?
  • Toothpaste Made From Hair Might Be The Future Of Your Dental Health
  • What Were The “Fireflies” NASA Astronaut John Glenn Saw As He Orbited The Earth?
  • Over 1,300-Year-Old Skeletons Buried In England Had West African Roots
  • Meet The Tibetan Fox: Perfectly Adapted For Life In The Plains With A 10/10 Side-Eye
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version